Cited 6 times in
Alpha-fetoprotein-producing gastric cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 노성훈 | - |
dc.contributor.author | 노재경 | - |
dc.contributor.author | 라선영 | - |
dc.contributor.author | 유내춘 | - |
dc.contributor.author | 정현철 | - |
dc.date.accessioned | 2020-07-02T17:08:22Z | - |
dc.date.available | 2020-07-02T17:08:22Z | - |
dc.date.issued | 1998 | - |
dc.identifier.issn | 1021-335X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/176618 | - |
dc.description.abstract | We measured the sero-positivity rate of serum alpha-fetoprotein (alphaFP) of gastric cancer patients by ELISA assay; forty-two curatively resected patients, 14 palliatively resected patients, 8 who received explo-laparotomy or bypass surgery and 18 patients with systemic metastasis. The sero-positive rate was 9.8% (8/82) and the positivity increased with cancer progression. Sex, age and pathological type were similar between alphaFP-positive and -negative patients. The overall synchronous hepatic metastasis rates in alphaFP-positive and alphaFP-negative groups were 37.5% (3/8) and 12.2% (9/74), respectively (p=0.08). The predictability of synchronous liver metastasis in eight alphaFP-positive patients were as follows: 37. 5% of total patients (3/8), 50.0% (3/6) of unresectable patients, and 60.0% (3/5) of patients with systemic metastasis. In three alphaFP-positive patient with liver metastasis, all the hepatic lesions were intrahepatic and multiple, while in alphaFP-negative patients, 67% (6/9) of the hepatic lesions was single intrahepatic lesion or surface nodule. The predictability of both synchronous and metachronous liver metastasis in alphaFP-positive gastric cancer patients was 75%. These findings suggested that, in advanced stomach cancer patients, especially in stage IV, alphaFP can be used in predicting liver metastasis during follow-up. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | D.A. Spandidos | - |
dc.relation.isPartOf | ONCOLOGY REPORTS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms/blood | - |
dc.subject.MESH | Liver Neoplasms/epidemiology | - |
dc.subject.MESH | Liver Neoplasms/pathology | - |
dc.subject.MESH | Liver Neoplasms/secondary* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoplasm Metastasis | - |
dc.subject.MESH | Palliative Care | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Stomach Neoplasms/blood* | - |
dc.subject.MESH | Stomach Neoplasms/mortality | - |
dc.subject.MESH | Stomach Neoplasms/pathology* | - |
dc.subject.MESH | Stomach Neoplasms/surgery | - |
dc.subject.MESH | Survival Rate | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | alpha-Fetoproteins/analysis* | - |
dc.subject.MESH | alpha-Fetoproteins/biosynthesis | - |
dc.title | Alpha-fetoprotein-producing gastric cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학교실) | - |
dc.contributor.googleauthor | RUTH LEE | - |
dc.contributor.googleauthor | SUN YOUNG RH | - |
dc.contributor.googleauthor | JOONG BAE AHN | - |
dc.contributor.googleauthor | KW ANG YONG SHIM | - |
dc.contributor.googleauthor | JIN HYUK CHOI | - |
dc.contributor.googleauthor | HO YOUNG LI | - |
dc.contributor.googleauthor | NAE CHOON YOO | - |
dc.contributor.googleauthor | SUNG HOON NOH | - |
dc.contributor.googleauthor | JOO HANG KIM | - |
dc.contributor.googleauthor | JAE KYUNG ROH | - |
dc.contributor.googleauthor | JIN SIK MIN | - |
dc.contributor.googleauthor | B YUNG SOO KIM | - |
dc.contributor.googleauthor | HYUN CHEOL CHUNG | - |
dc.identifier.doi | 10.3892/or.5.5.1179 | - |
dc.contributor.localId | A01281 | - |
dc.contributor.localId | A01290 | - |
dc.contributor.localId | A01316 | - |
dc.contributor.localId | A02457 | - |
dc.contributor.localId | A03773 | - |
dc.relation.journalcode | J02419 | - |
dc.identifier.eissn | 1791-2431 | - |
dc.identifier.pmid | 9683831 | - |
dc.identifier.url | https://www.spandidos-publications.com/or/5/5/1179 | - |
dc.contributor.alternativeName | Noh, Sung Hoon | - |
dc.contributor.affiliatedAuthor | 노성훈 | - |
dc.contributor.affiliatedAuthor | 노재경 | - |
dc.contributor.affiliatedAuthor | 라선영 | - |
dc.contributor.affiliatedAuthor | 유내춘 | - |
dc.contributor.affiliatedAuthor | 정현철 | - |
dc.citation.volume | 5 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1179 | - |
dc.citation.endPage | 1184 | - |
dc.identifier.bibliographicCitation | ONCOLOGY REPORTS, Vol.5(5) : 1179-1184, 1998 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.